Now showing items 1-1 of 1

    • Telavancin in the treatment of invasive Gram-positive infections 

      Keynan, Yoav; Rubinstein, Ethan (Department of Medical Microbiology, 2012)
      Telavancin is a newer once-daily lipoglycopeptide with activity against Gram-positive bacteria, including those that are resistant to conventional antibiotics like beta-lactams. The results of recent clinical trials led ...